Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / JNJ - Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? | Benzinga

JNJ - Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? | Benzinga

Johnson & Johnson

Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to proceed with CD388 (JNJ-0953), which is being developed for the universal prevention of influenza A and B. 

As part of a recent prioritization of its R&D business, in July, Janssen announced its intention to discontinue the internal development of most of its infectious disease pipeline, Full story available on Benzinga.com
Stock Information
Company Name: Johnson & Johnson
Stock Symbol: JNJ
Market: NYSE
Website: jnj.com
Menu
JNJ JNJ Quote JNJ Short JNJ News JNJ Articles JNJ Message Board
Get JNJ Alerts

News, Short Squeeze, Breakout and More Instantly...